ReviewThe oncologist2026

The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer.

Philipose Mulugeta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.